Correlation Between Sosei Group and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sosei Group and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sosei Group and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sosei Group and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Sosei Group and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sosei Group with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sosei Group and Rigel Pharmaceuticals.
Diversification Opportunities for Sosei Group and Rigel Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sosei and Rigel is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Sosei Group and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Sosei Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sosei Group are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Sosei Group i.e., Sosei Group and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sosei Group and Rigel Pharmaceuticals
Assuming the 90 days horizon Sosei Group is expected to under-perform the Rigel Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Sosei Group is 1.88 times less risky than Rigel Pharmaceuticals. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 1,220 in Rigel Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 1,541 from holding Rigel Pharmaceuticals or generate 126.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 99.32% |
| Values | Daily Returns |
Sosei Group vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| Sosei Group |
| Rigel Pharmaceuticals |
Sosei Group and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sosei Group and Rigel Pharmaceuticals
The main advantage of trading using opposite Sosei Group and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sosei Group position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| Sosei Group vs. Gain Therapeutics | Sosei Group vs. Biovie Inc | Sosei Group vs. In8bio Inc | Sosei Group vs. NewAmsterdam Pharma |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |